steer trial semaglutide Semaglutides Are Poised to Remake Chronic Kidney Disease Care-sk 📌 Most viewed this week

Virtual Consult

GLP1 medications do more than support weight lossthey can play a meaningful role in heart health, blood sugar control and even sleep quality

But thus far, the data dont show this.

We applied 5% annual discounting for health economic outcomes

PALO ALTO, Calif., September 28, 2023 (BUSINESS WIRE)-- Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced today the launch of its latest innovation in obesity care, Digbi GLP-Fit, a scientifically-backed approach to identify the best treatment path for an individual to prevent and treat obesity. Key Highlights: Digbi GLP-Fit uses the science of precision biology to identify the best treatment path for obesity for an individual with 87% accuracy, which may include 1) only precision nutrition, 2) a combination of precision nutrition and lower-cost drugs like Metformin, or 3) a combination of precision nutrition and GLP-1 medications